- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 263/20 - Oxygen atoms attached in position 2
Patent holdings for IPC class C07D 263/20
Total number of patents in this class: 161
10-year publication summary
|
10
|
19
|
7
|
10
|
6
|
7
|
2
|
7
|
2
|
5
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Modernatx, Inc. | 1289 |
10 |
| Merck Sharp & Dohme LLC | 3728 |
8 |
| Lee Pharma Limited | 17 |
6 |
| Synthon BV | 309 |
6 |
| The Global Alliance for TB Drug Development, Inc. | 41 |
5 |
| Merck Sharp & Dohme Corp. | 2183 |
4 |
| Bristol-myers Squibb Company | 4721 |
3 |
| Genentech, Inc. | 4101 |
3 |
| Zhejiang Huahai Pharmaceutical Co., Ltd. | 218 |
3 |
| F. Hoffmann-La Roche AG | 7832 |
2 |
| BASF SE | 21292 |
2 |
| Janssen Pharmaceutica N.V. | 3177 |
2 |
| Bayer Cropscience AG | 1851 |
2 |
| The Regents of the University of Michigan | 4964 |
2 |
| The Board of Trustees of the University of Illinois | 2749 |
2 |
| Arbor Pharmaceuticals, LLC | 64 |
2 |
| Changzhou Yabang Pharmaceutical Co., Ltd | 2 |
2 |
| Consejo Superior de Investigaciones Cientificas (csic) | 1441 |
2 |
| Galderma Research & Development | 359 |
2 |
| Jubilant Life Sciences Limited | 30 |
2 |
| Other owners | 91 |